Shuhei Fujita, MD, PhD is the VP and Therapeutic Area head of Medical Affairs Japan in Astellas. In this role, Dr. Fujita provides leadership for the Medical Affairs organization and leads the MA strategy for all product in Japan. Dr. Fujita joined Astellas in 2017 as a Global Medical Lead at Development and moved to Medical Affairs from 2019. While at Development, he successfully led and executed the clinical development and global medical programs in both of oncology and non-oncology therapeutic area. Prior to joining Astellas, Dr. Fujita held the position of physician scientist and conducted the translational science program through the collaboration with pharmaceutical companies at National Cancer Center in Japan. Dr. Fujita received his bachelor degree of science from the University of Tokyo, Japan. He went on to receive his medical degree from Tokyo Medical and Dental University, Japan. After the clinical experiences at surgery and oncology fields, Dr Fujita competed the PhD program at the same medical school.